Sono-Tek Corp (SOTK) 10-Q Summary
Business Context and Reporting Period
Sono-Tek Corp designs and manufactures ultrasonic coating systems for microelectronics, medical, alternative energy, and industrial markets. This report covers the quarterly period ended August 31, 2022 (Second Quarter of Fiscal 2023) and the six-month period ended August 31, 2022 (First Half of Fiscal 2023). The company is a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended Aug 31, 2022 | Six Months Ended Aug 31, 2022 |
|---|---|---|
| Net Sales | $3,763,329 | $7,814,864 |
| Gross Profit | $1,895,613 | $4,002,626 |
| Gross Margin | 50.4% | 51.2% |
| Operating Income | $177,578 | $558,103 |
| Net Income | $162,123 | $467,759 |
| Diluted EPS | $0.01 | $0.03 |
| Cash & Cash Equivalents | $4,309,057 | $4,309,057 |
| Marketable Securities | $6,347,854 | $6,347,854 |
| Total Debt | $0 | $0 |
| Working Capital | $11,360,754 | $11,360,754 |
Note: The company has no outstanding debt. A $1.5 million revolving line of credit is available with $1.495 million unused.
Material Changes vs. Prior Period
- Revenue: Net sales decreased 8% ($307,000) in the second quarter compared to the prior year, primarily due to delayed shipments caused by supply chain constraints. For the six-month period, sales increased 1% ($100,000) driven by strong medical and industrial sales.
- Profitability: Operating income decreased 60% ($271,000) in the quarter due to lower gross profit and increased operating expenses. Net income for the six-month period decreased significantly ($1.14 million) compared to the prior year, largely due to the absence of a $1.0 million Paycheck Protection Program (PPP) loan forgiveness gain recorded in the prior year.
- Expenses: Operating expenses increased 6% in the quarter and 11% for the six-month period. Increases were driven by inflationary salary adjustments, higher R&D material costs, and increased travel/trade show expenses as COVID-19 restrictions lifted.
- Geographic Mix: Sales to the Asia Pacific (APAC) region decreased 49% in the quarter due to COVID-19 lockdowns in China. Conversely, sales in the U.S., EMEA, and Latin America grew.
Outlook, Risks, and Management Commentary
- Supply Chain: Management anticipates supply chain issues will continue to impact revenue through the third quarter of fiscal 2023, with delayed shipments expected to result in increased shipments in the fourth quarter. Three large system orders totaling $319,000 were delayed to Q3.
- Backlog: Order backlog stood at $5,049,000 as of August 31, 2022, a 19% increase from the previous quarter but a 5% decrease from the prior fiscal year-end. Growth in the clean energy sector contributed to the backlog increase.
- Risks: Key risks include global supply chain shortages (particularly electronic components), inflationary pressures on energy and materials, and the ongoing impact of the COVID-19 pandemic on manufacturing facilities in China and customer demand.
- Market Trends: The Industrial market grew 77% in the quarter, driven by a new roll-to-roll coating system. The Medical market saw a 36% increase for the six-month period.
Investor Verification Checklist
- Verify the timing of the $319,000 in delayed system orders and their expected recognition in Q3 or Q4.
- Monitor the recovery of APAC sales volumes as China manufacturing restrictions ease.
- Assess the sustainability of the 51.2% gross margin given inflationary cost pressures on raw materials and labor.
- Review the utilization of the $1.5 million credit line if cash flow tightens due to continued inventory build-up.
- Confirm the status of the seven coating machines valued at $216,000 each scheduled for shipment in the second half of fiscal 2023.